All animals received a subcutaneous injection of 2.5 mg of medroxyprogesterone acetate (Depo-Provera, Pfizer) one week prior to challenge. Three weeks after the final vaccination, mice were challenged intra-vaginally with 107 IFU of Ct serovar D/UW3/Cx EBs as previously described [7] (link), [17] (link). Cervico-vaginal swabs were obtained on days 1, 3, 7, 14 and 22 post-challenge, and the total number of inclusions per well were enumerated in a blinded fashion using fluorescence microscopy.
Free full text: Click here